Vivo Medtech ApS: Financial statements 2024
CVR: 44678675
Source: annual report 2024, Danish Business Authority
28/02/2024 – 31/12/2024
Vivo Medtech ApS (CVR 44678675) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 75,052 and a net result of DKK -6,178. Equity in the 2024 report amounted to DKK 33,822. The solvency ratio was 30%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 75,052
- Profit/Loss
- DKK -6,178
- Equity
- DKK 33,822
- Total Assets
- DKK 112,760
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of February 28, 2024, Frederik Penzien Wainer Mamsen is registered as adm. dir. of Vivo Medtech ApS.
Vivo Medtech ApS was founded on February 28, 2024.
About Vivo Medtech ApS
Vivo Medtech ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 2024. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Nicolai Pelé Penzien Mamsen and Simon Weiss Bonde. The company is owned by Manola ApS, NM Holding 2025 ApS and Simbo Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 199,640 and a net result of DKK -34,745 compared with DKK -6,178 the year before. Equity in the 2025 report amounted to DKK -923.